Opaleye Management Inc. Portfolio Holdings

Opaleye Management Inc.

  • $411 Million
  • Q1 2024

Opaleye Management Inc. has filed its 13F form on May 29, 2024 for Q1 2024 where it was disclosed a total value porftolio of $411 Million distributed in 52 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Ocular Therapeutix, Inc with a value of $60.5M, Harrow Health, Inc. with a value of $51.9M, Tg Therapeutics, Inc. with a value of $34.7M, Keros Therapeutics, Inc. with a value of $24.3M, and Rhythm Pharmaceuticals, Inc. with a value of $22.3M.

Examining the 13F form we can see an increase of $3.93M in the current position value, from $407M to 411M.

Opaleye Management Inc. is based out at Boston, MA

Below you can find more details about Opaleye Management Inc. portfolio as well as his latest detailed transactions.

Portfolio value $411 Million
Healthcare: $411 Million

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$439M
$60.5 Million 14.73% of portfolio
6,653,138
Q1 2024 Added 9.61%
$486M
$51.9 Million 12.62% of portfolio
3,920,600
Q1 2024 Added 2.63%
$2.37B
$34.7 Million 8.44% of portfolio
2,280,000
Q1 2024 Added 2.93%
$1.21B
$24.3 Million 5.92% of portfolio
367,500
Q1 2024 Added 2.8%
$1.99B
$22.3 Million 5.43% of portfolio
515,000
Q1 2024 Reduced 15.57%
$1.66B
$16 Million 3.9% of portfolio
1,004,355
Q1 2024 Reduced 20.11%
$1.76B
$13.6 Million 3.31% of portfolio
330,000
Q1 2024 Added 25.14%
$1.4B
$13.3 Million 3.23% of portfolio
897,000
Q4 2023 Added 47.05%
$1.08B
$12.1 Million 2.95% of portfolio
665,000
Q1 2024 Reduced 4.86%
$206M
$12 Million 2.93% of portfolio
1,770,000
Q1 2024 Added 62.01%
$776M
$11 Million 2.67% of portfolio
344,123
Q1 2024 Added 11.55%
$221M
$10.9 Million 2.65% of portfolio
3,120,000
Q1 2024 Added 2.45%
$31.7M
$10.8 Million 2.63% of portfolio
2,692,594
Q4 2022 Reduced 0.57%
$2.39B
$9.83 Million 2.39% of portfolio
210,000
Q1 2024 Reduced 31.71%
$89.8M
$9.17 Million 2.23% of portfolio
2,445,781
Q1 2024 Reduced 3.32%
$150M
$9.13 Million 2.22% of portfolio
2,645,000
Q1 2024 Added 4.34%
$270M
$7.07 Million 1.72% of portfolio
1,285,000
Q1 2024 Added 12.72%
$1.63B
$7.02 Million 1.71% of portfolio
255,000
Q1 2024 Added 157.58%
$143M
$6.28 Million 1.53% of portfolio
3,170,000
Q1 2024 New
$295M
$6.01 Million 1.46% of portfolio
250,000
Q4 2023 Reduced 8.93%
$828M
$5.83 Million 1.42% of portfolio
395,000
Q1 2024 Reduced 11.24%
$4.17B
$5.81 Million 1.41% of portfolio
85,000
Q1 2024 Reduced 5.56%
$466M
$4.26 Million 1.04% of portfolio
855,000
Q1 2024 New
$302M
$4.05 Million 0.99% of portfolio
270,000
Q1 2024 Reduced 15.63%
$743M
$3.93 Million 0.96% of portfolio
267,210
Q1 2024 New
$234M
$3.86 Million 0.94% of portfolio
785,000
Q1 2024 New
$85.8M
$3.53 Million 0.86% of portfolio
759,000
Q1 2024 Reduced 13.45%
$1.38B
$3.26 Million 0.79% of portfolio
112,700
Q4 2023 New
$677M
$3.15 Million 0.77% of portfolio
200,000
Q1 2024 New
$106M
$3.07 Million 0.75% of portfolio
2,435,000
Q1 2024 New
$55.4M
$2.88 Million 0.7% of portfolio
2,440,109
Q1 2024 Reduced 18.18%
$23.4M
$1.6 Million 0.39% of portfolio
1,630,000
Q1 2024 Added 25.67%
$31.6M
$1.53 Million 0.37% of portfolio
1,108,357
Q1 2024 Added 13.68%
$291M
$1.37 Million 0.33% of portfolio
947,500
Q1 2024 Reduced 6.42%
$346M
$1.32 Million 0.32% of portfolio
174,413
Q1 2024 Reduced 72.03%
$409M
$1.23 Million 0.3% of portfolio
130,000
Q4 2023 New
$2.51B
$1.18 Million 0.29% of portfolio
65,000
Q1 2024 Reduced 55.17%
$5.37B
$808,000 0.2% of portfolio
8,576
Q1 2024 New
$83M
$801,000 0.19% of portfolio
471,481
Q1 2024 New
$57.2M
$764,000 0.19% of portfolio
534,657
Q1 2024 Added 7.69%
$33.5M
$490,000 0.12% of portfolio
170,308
Q1 2024 New
$226M
$455,000 0.11% of portfolio
113,038
Q1 2024 New
$146M
$318,000 0.08% of portfolio
67,561
Q1 2024 New
Syros Pharmaceuticals Inc
-
$0 0.0% of portfolio
-
Q1 2024 Added 119.15%
Gossamer Bio Inc
-
$0 0.0% of portfolio
-
Q3 2023 New
Jasper Therapeutics Inc
-
$0 0.0% of portfolio
-
Q1 2024 New
Ibio Inc
-
$0 0.0% of portfolio
-
Q1 2024 New
Nyxoah S A
-
$0 0.0% of portfolio
-
Q1 2024 Reduced 7.19%
Verastem Inc
-
$0 0.0% of portfolio
-
Q3 2023 Added 107.25%

Summary

  • Portfolio
  • No. of Stocks 52
  • Current Value $411 Million
  • Prior Value $407 Million
  • Filing
  • Period Q1 2024
  • Filing Date May 29, 2024
  • Form Type 13F-HR/A
  • Activity in Q1 2024
  • New Purchases 1 stocks
  • Additional Purchases 0 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 0 stocks
Track This Portfolio

Track Opaleye Management Inc. Portfolio

Follow Opaleye Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Opaleye Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Opaleye Management Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email